A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma or COPD with type…

Asthma AcuteCOPD Exacerbation Acute

~Estimated

~$10 – $8,750

Connect Biopharm LLCNCT07705737

Observational

The Reducing Respiratory Emergency Visits Using Implementation Science Interventions Tailored to Setting (REVISITS) Study: A Cluster Randomized Trial

This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition prog…

COPDCOPD Exacerbation Acute

~Estimated

~$10 – $6,250

University of ChicagoNCT05568043

Observational

Neuromuscular Electrical Stimulation (NMES) in Patients Hospitalized With Acute Exacerbation of COPD and/or Community Acquired Pneumonia

In older adults hospitalized for acute medical conditions, immobility, clinical treatments, and the illness itself contribute to physical deconditioning and de…

Community-acquired PneumoniaCOPD Exacerbation Acute

~Estimated

~$10 – $6,250

University of VermontNCT05452226